Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis

Bibliographic Details
Main Authors:	Rabquer, Bradley J, Tsou, Pei-Suen, Hou, Yong, Thirunavukkarasu, Eshwar, Haines, G Kenneth, Impens, Ann J, Phillips, Kristine, Kahaleh, Bashar, Seibold, James R, Koch, Alisa E
Format:	Online
Language:	English
Published:	BioMed Central 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241362/

Similar Items

IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
by: Maruoka, Hayato, et al.
Published: (2013)

MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis
by: Tworek, Damian, et al.
Published: (2013)

SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
by: Sharma, Sherven, et al.
Published: (2003)

An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
by: Yates-Binder, Cecelia C., et al.
Published: (2012)

Macrophages induce differentiation of plasma cells through CXCL10/IP-10
by: Xu, Wei, et al.
Published: (2012)

IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer
by: Lunardi, Serena, et al.
Published: (2015)

Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease
by: Rocha, Natália Pessoa, et al.
Published: (2014)

CXCL4 and CXCL10 Predict Risk of Fatal Cerebral Malaria
by: Wilson, Nana O., et al.
Published: (2011)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
by: Wang, Cuini, et al.
Published: (2016)

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
by: Fenwick, Peter S., et al.
Published: (2015)

Seminal Levels of Pro-inflammatory (CXCL1, CXCL9, CXCL10) and Homeostatic (CXCL12) Chemokines in Men With Asymptomatic Chlamydia trachomatis Infection
by: Hakimi, Hamid, et al.
Published: (2014)

Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies
by: Proost, Paul, et al.
Published: (2006)

Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10
by: Vujanovic, Lazar, et al.
Published: (2012)

The role of CXCL10 in the pathogenesis of experimental septic shock
by: Herzig, Daniela S, et al.
Published: (2014)

The Multifaceted Functions of CXCL10 in Cardiovascular Disease
by: van den Borne, Pleunie, et al.
Published: (2014)

Increased expression of Cxcr3 and its ligands, Cxcl9, and Cxcl10, during the development of alopecia areata in the mouse
by: McPhee, Caroline G., et al.
Published: (2012)

Identification of genes differentially expressed in T cells following stimulation with the chemokines CXCL12 and CXCL10
by: Nagel, JE, et al.
Published: (2004)

Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
by: Karason, Kristjan, et al.
Published: (2006)

CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
by: Sato, Tomoo, et al.
Published: (2013)

Myocardial Chemokine Expression and Intensity of Myocarditis in Chagas Cardiomyopathy Are Controlled by Polymorphisms in CXCL9 and CXCL10
by: Nogueira, Luciana Gabriel, et al.
Published: (2012)

CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model
by: ZHUANG, JIAWEI, et al.
Published: (2014)

CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
by: Bronger, Holger, et al.
Published: (2016)

Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still’s disease
by: Han, Jae Ho, et al.
Published: (2015)

Progranulin inhibits expression and release of chemokines CXCL9 and CXCL10 in a TNFR1 dependent manner
by: Mundra, Jyoti Joshi, et al.
Published: (2016)

IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
by: Lunardi, Serena, et al.
Published: (2014)

Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF
by: Di Cesare, Sebastian, et al.
Published: (2007)

CXCL10 Gene Promoter Polymorphism -1447A>G Correlates with Plasma CXCL10 Levels and is Associated with Male Susceptibility to Cerebral Malaria
by: Wilson, Nana, et al.
Published: (2013)

Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator
by: Mehla, Rajeev, et al.
Published: (2012)

CXCL8 – The First Chemokine
by: Baggiolini, Marco
Published: (2015)

Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans
by: Segers, Dolf, et al.
Published: (2011)

CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis
by: Agostini, Carlo, et al.
Published: (2005)

CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis
by: Martini, Georgia, et al.
Published: (2005)

Lethal Nipah Virus Infection Induces Rapid Overexpression of CXCL10
by: Mathieu, Cyrille, et al.
Published: (2012)

Protein expression and gene polymorphism of CXCL10 in patients with colorectal cancer
by: DIMBERG, JAN, et al.
Published: (2014)

CXCL10 and blood-brain barrier modulation in rabies virus infection
by: Gnanadurai, Clement W., et al.
Published: (2016)

Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome
by: Wightman, S C, et al.
Published: (2015)

Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT
by: Bonechi, Elena, et al.
Published: (2014)

Antimicrobial Activity of Chemokine CXCL10 for Dermal and Oral Microorganisms
by: Holdren, Grant O., et al.
Published: (2014)

Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10
by: Ho, Julie, et al.
Published: (2016)

CXCL10 Acts as a Bifunctional Antimicrobial Molecule against Bacillus anthracis
by: Margulieux, Katie R., et al.
Published: (2016)